Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.
Ubrogepant (Ubrelvy) is the first oral calcitonin gene-related peptide receptor antagonist approved by the FDA for the acute treatment of migraine.
Fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo and AstraZeneca) is a new treatment option for patients with HER2-positive breast cancer who have progressed after 2 or more prior regimens.
A set of performance measures for older adults with type 2 diabetes at greater risk for hypoglycemia published by the Endocrine Society and Avalere Health.
A study examined influenza vaccination requirements for children who attend child care centers.
Officials with the FDA have approved a new indication and label expansion for icosapent ethyl (Vascepa, Amarin).
One in 5 older adults said that they’ve taken leftover antibiotics from a previous prescription without checking in with a health care professional.
Louisiana, along with other southern and southwestern US states, topped the Walgreens Flu Index report for highest incidences of flu for November.
A new study shows increases in the misuse of non-opioid medications among US adults coinciding with decreases in opioid prescribing.
Pharmacist-led initiatives, such as medication therapy management, for chronic diseases can significantly improve patient outcomes.